Cellectar Biosciences Inc...

NASDAQ: CLRB · Real-Time Price · USD
4.37
-0.05 (-1.13%)
At close: Aug 15, 2025, 3:59 PM
4.74
8.47%
After-hours: Aug 15, 2025, 05:55 PM EDT

Cellectar Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
291.65K 192.38K 238.87K 227.64K
Gross Profit
-291.65K -192.38K -238.87K -227.64K
Operating Income
-51.78M -38.96M -28.81M -24.13M
Interest Income
1.21M 387.15K 152.52K 2.28K
Pretax Income
-44.52M -38.04M -28.66M -24.12M
Net Income
-44.58M -37.98M -28.6M -24.12M
Selling & General & Admin
25.64M 11.69M 9.59M 6.54M
Research & Development
26.14M 27.27M 19.22M 17.59M
Other Expenses
-291.65K n/a n/a n/a
Operating Expenses
51.49M 38.96M 28.81M 24.13M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a 945.18K n/a n/a
Cost & Expenses
51.78M 38.96M 28.81M 24.13M
Income Tax Expense
66K -60K -60K -152.2K
Shares Outstanding (Basic)
36.62M 12.22M 7.06M 5.55M
Shares Outstanding (Diluted)
37.14M 12.22M 7.06M 5.55M
EPS (Basic)
-1.22 -3.11 -4.05 -4.35
EPS (Diluted)
-1.2 -3.11 -4.05 -4.35
EBITDA
-44.22M -38.77M -28.67M -23.98M
EBIT
-44.52M -38.96M -28.81M -24.12M
Depreciation & Amortization
291.65K 192.38K 238.87K 227.64K